r&d

The report provides an assessment of the economic value of medical research to challenge economists who are inclined to be skeptical about the efficiency of the “market” for health services in
general and government directed medical research in particular.

SSTIs President and Research Director co-authored the report that identifies research and development (R&D) as a fundamental economic development building block in the new economy and calls on states to invest in universities and the private sector as ways to ensure that they have strong R&D bases.

The data brief from the National Science Foundation reports that two-thirds of all U.S. research and development (R&D) expenditures in 1997 were concentrated in just ten states. The brief also graphically presents the ten-year trends for state R&D expenditures. Also of note are the state rankings by R&D intensity, as measured by R&D expenditures as a percentage of gross state product.

Battelle Memorial Institute and the National Science Foundation report indicates total research and development investment in the United States was strong in 2000, and is expected to increase about five percent in 2001. Battelle predicts that industry will continue to emphasize various forms of partnering and collaborations, including relationships with other industry, federal laboratories and international facilities.

The study by Stanford Institute for Economic Policy Research uses the pharmaceutical industry as a case study, and suggests that the economic return on publicly funded basic research is substantial but on a time dimension that may be greater than most state and local leaders are anticipating.

The statistical report from the National Science Foundation reflect research and development funding levels as reported by 32 Federal agencies for fiscal years 1997-99.

The report found that in FY 1997, the seven agencies it reviewed participated in 575 international science and technology agreements with 57 countries, 8 international organizations, and 10 groups or organizations and/or countries. More than 90% of the international S&T agreements resulted in research projects or other research-related activities such as consultations among scientists and exchanges of data and personnel.

The report finds that during the 1990s, states increasingly have included an S&T component in their economic development plans, and between 1991 and 1995 no fewer than thirteen states adopted statewide S&T strategic plans of varying levels of sophistication and complexity.

Survey data on the various sectors of the U.S. economy including industry, government, academia, and selected nonprofits are aggregated within this report so that the components of the overall R&D effort are placed in a national context.

The report introduces the U.S. Corporate research and development (R&D) data series to provide new information and context on the R&D activity of the Nation’s top 500 R&D spending corporations. Data is based on the Standard and Poor’s Compustat database.